[go: up one dir, main page]

UA88462U - Solid dosage form of drug with sedative and hypnotic effects - Google Patents

Solid dosage form of drug with sedative and hypnotic effects

Info

Publication number
UA88462U
UA88462U UAU201313751U UAU201313751U UA88462U UA 88462 U UA88462 U UA 88462U UA U201313751 U UAU201313751 U UA U201313751U UA U201313751 U UAU201313751 U UA U201313751U UA 88462 U UA88462 U UA 88462U
Authority
UA
Ukraine
Prior art keywords
dosage form
sedative
drug
solid dosage
hypnotic effects
Prior art date
Application number
UAU201313751U
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Лукич Драган
Original Assignee
Иммуниал Энтерпрайзис Лимитед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Иммуниал Энтерпрайзис Лимитед filed Critical Иммуниал Энтерпрайзис Лимитед
Priority to UAU201313751U priority Critical patent/UA88462U/en
Publication of UA88462U publication Critical patent/UA88462U/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

The solid dosage form of the drug with sedative and hypnotic effects in the form of the tablet or hard capsule contains ethyl ester of α-bromoisovaleric acid and mint oil or the mixture of mint oil and hop oil, β-cyclodextrin and excipients. In addition, the dosage form contains doxilamine, guaifenesin, and the structured water.
UAU201313751U 2013-11-26 2013-11-26 Solid dosage form of drug with sedative and hypnotic effects UA88462U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAU201313751U UA88462U (en) 2013-11-26 2013-11-26 Solid dosage form of drug with sedative and hypnotic effects

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAU201313751U UA88462U (en) 2013-11-26 2013-11-26 Solid dosage form of drug with sedative and hypnotic effects

Publications (1)

Publication Number Publication Date
UA88462U true UA88462U (en) 2014-03-11

Family

ID=52299127

Family Applications (1)

Application Number Title Priority Date Filing Date
UAU201313751U UA88462U (en) 2013-11-26 2013-11-26 Solid dosage form of drug with sedative and hypnotic effects

Country Status (1)

Country Link
UA (1) UA88462U (en)

Similar Documents

Publication Publication Date Title
MX2021000550A (en) Tofacitinib oral sustained release dosage forms.
MX2021003230A (en) PHARMACEUTICAL COMPOSITIONS COMPRISING MELOXICAM.
CL2015002148A1 (en) Pharmaceutical formulations resistant to improper handling
EP4512394A3 (en) Dosage forms and use thereof
MX2020002693A (en) Stabilized pharmaceutical formulations of insulin analogues and/or insulin derivatives.
EA201690679A1 (en) STABLE PHARMACEUTICAL COMPOSITION CONTAINING AMLODIPIPIN AND VALSARTAN
BR112015023523B8 (en) PHARMACEUTICAL COMPOSITIONS AND SINGLE DOSAGE FORM CONTAINER
MX344846B (en) COMBINATION OF ACTIVE LOADED GRANULES WITH ADDITIONAL ASSETS.
MX353061B (en) Novel low concentration meloxicam tablets.
EA201400737A1 (en) DELIVERY SYSTEM ON THE BASIS OF A PELLET SET WITH IMMEDIATE release of an ACTIVE SUBSTANCE
MX2016006087A (en) Rapidly disintegrating formulations and methods of use.
PH12015502108A1 (en) Pharmaceutical combination drug
MX2016015261A (en) Allisartan isoproxil solid dispersion and pharmaceutical composition thereof.
TR201010683A1 (en) Vildagliptin formulations.
UY34931A (en) ? COMPOSITE FORMULATION FOR ORAL ADMINISTRATION THAT INCLUDES METFORMIN AND ROSUVASTATIN ?.
UA119441C2 (en) Glycogen-based water solubility enhancers
CL2016000397A1 (en) Cancer treatment
IN2014DN06617A (en)
MX2015015537A (en) Nicotine lozenge formulation.
MX381450B (en) A combination medicine comprising phenylephrine and paracetamol
UA88462U (en) Solid dosage form of drug with sedative and hypnotic effects
EA201692426A1 (en) COMBINATIONS OF ZALTOPROFENA AND MIORELAXANT
UA89626U (en) Solid dosage form of sedative and hypnotic drug
NZ702849A (en) Genotype- or phenotype-based drug formulation
UA111358C2 (en) Drug in form of tablets or hard capsules exhibiting sedative and hypnotic effects